Escherichia coli DNA (E. coli DNA)

Escherichia coli DNA is the circular, double-stranded genetic blueprint of the bacterium, typically comprising approximately 4.6 million base pairs that encode over 4,000 genes essential for cellular survival and virulence [3, 7]. In clinical pharmacology, this nucleic acid is a primary therapeutic target for agents that seek to arrest bacterial proliferation or induce rapid cell death by compromising genetic integrity [11, 21]. Certain drug classes, such as nitroimidazoles, are biochemically reduced within the bacterial cytoplasm to form reactive radicals that cause extensive DNA strand fragmentation and loss of helical structure [11]. Additionally, the DNA molecule serves as the site for the lethal action of topoisomerase poisons like fluoroquinolones, which trap enzymes such as DNA gyrase on the DNA backbone to create toxic, permanent double-strand breaks [1, 21]. Because E. coli is a frequent cause of infections ranging from uncomplicated urinary tract infections to life-threatening sepsis, targeting its DNA remains a cornerstone of antimicrobial strategy [2, 12, 17]. However, the therapeutic window of these agents is often constrained by potential toxicity to host mitochondrial DNA and the rapid emergence of resistance through mutations in the genes encoding DNA-processing enzymes [16, 21].

Other names

Escherichia coli genomic DNABacterial chromosomal DNAGenomic DNAEscherichia coli chromosome

Drugs targeting Escherichia coli DNA function by inducing direct physical damage, such as strand breakage and alkylation, or by stabilizing DNA-enzyme intermediates (e.g., topoisomerase-cleavage complexes) that result in irreversible double-strand breaks and inhibition of replication [1, 11, 21].